Lv2
160 积分 2024-10-26 加入
A randomized phase 2 Trial of romiplostim N01 versus recombinant human thrombopoietin for promoting platelet engraftment after allogeneic hematopoietic stem cell transplantation
3天前
求助中
Herombopag for the treatment of persistent thrombocytopenia following hematopoietic stem cell transplantation
4天前
已完结
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
6天前
已完结
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation
6天前
已完结
Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation
6天前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
2个月前
已完结
Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study)
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells for relapsed or refractory multiple myeloma: is 1 + 1 greater than 2?
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
6个月前
已完结
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
7个月前
已完结
皖公网安备34019202002308
